Talk:Mylan

Viatris
Not sure of the protocol here, but should there not be a separate Viatris article? At the very least, the Viatris page should not link to Mylan. After all, Pfizer shareholders owned more than half of this business after the transaction. In other words, Viatris is mostly Pfizer's Upjohn subsidiary, not Mylan. So if anything, the Viatris page should be the Upjohn page, not the Mylan page. But more likely, I would imagine there should be a separate page for Viatris with Mylan and Pfizer having links as appropriate. ask123 (talk) 14:38, 6 October 2022 (UTC)

EpiPens
I think the section on EpiPens should be expanded. On the one hand, after buying the EpiPen company, Mylan increased the price four-fold; on the other hand, the pens supplied to school are supplied free-of-charge. Mylan says it has also given out other free pens. See https://www.forbes.com/sites/emilywillingham/2016/08/21/why-did-mylan-hike-epipen-prices-400-because-they-could/?sh=51ea6b1a280c, https://www.forbes.com/sites/kellyphillipserb/2016/08/24/that-400-epipen-price-hike-could-hit-your-wallet-even-if-you-dont-need-one/?sh=5dce67d94857, https://www.nbcnews.com/business/economy/epipen-price-hike-has-parents-kids-allergies-scrambling-ahead-school-n633071, https://www.talktomira.com/post/how-much-does-an-epipen-cost and other articles. Maybe some-one can bring this all together in a concise and accurate way. Kdammers (talk) 17:47, 25 October 2022 (UTC)

Duplicated information on stocks
There's a separate "Stocks" section, and in the "History" section there's an additional sub-section also called "Stocks" that is not listed chronologically and also duplicates the information given in the separate "Stocks" section. Nakonana (talk) 19:15, 18 July 2024 (UTC)